AAAAAA
Results:
1-11
|
Results: 11
Authors:
Hamy, F
Felder, E
Lipson, K
Klimkait, T
Citation: F. Hamy et al., Merged screening for human immunodeficiency virus Tat and Rev inhibitors, J BIOMOL SC, 6(3), 2001, pp. 179-187
Authors:
Hamy, F
Gelus, N
Zeller, M
Lazdins, JL
Bailly, C
Klimkait, T
Citation: F. Hamy et al., Blocking HIV replication by targeting Tat protein, CHEM BIOL, 7(9), 2000, pp. 669-676
Authors:
Daelemans, D
Schols, D
Witvrouw, M
Pannecouque, C
Hatse, S
van Dooren, S
Hamy, F
Klimkait, T
De Clercq, E
Vandamme, AM
Citation: D. Daelemans et al., A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: Inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry, MOLEC PHARM, 57(1), 2000, pp. 116-124
Authors:
Arimondo, PB
Gelus, N
Hamy, F
Payet, D
Travers, A
Bailly, C
Citation: Pb. Arimondo et al., The chromosomal protein HMG-D binds to the TAR and RBE RNA of HIV-1, FEBS LETTER, 485(1), 2000, pp. 47-52
Authors:
Brondani, V
Hamy, F
Citation: V. Brondani et F. Hamy, Retinoic acid switches differential expression of FGF8 isoforms in LNCaP cells, BIOC BIOP R, 272(1), 2000, pp. 98-103
Authors:
Hamy, F
Albrecht, G
Florsheimer, A
Bailly, C
Citation: F. Hamy et al., An ARE-selective DNA minor groove binder from a combinatorial approach, BIOC BIOP R, 270(2), 2000, pp. 393-399
Authors:
Gelus, N
Hamy, F
Bailly, C
Citation: N. Gelus et al., Molecular basis of HIV-1 TAR RNA specific recognition by an acridine tat-antagonist, BIO MED CH, 7(6), 1999, pp. 1075-1079
Authors:
Gelus, N
Bailly, C
Hamy, F
Klimkait, T
Wilson, WD
Boykin, DW
Citation: N. Gelus et al., Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: Effects of the terminal basic side chains, BIO MED CH, 7(6), 1999, pp. 1089-1096
Authors:
Lansiaux, A
Fabbro, D
Meyer, T
Hamy, F
Bailly, C
Citation: A. Lansiaux et al., PKC 412, B CANCER, 86(7-8), 1999, pp. 614-617
Authors:
Bailly, C
Carrasco, C
Hamy, F
Vezin, H
Prudhomme, M
Saleem, A
Rubin, E
Citation: C. Bailly et al., The camptothecin-resistant topoisomerase I mutant F361S is cross-resistantto antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles, BIOCHEM, 38(27), 1999, pp. 8605-8611
Authors:
Klimkait, T
Felder, ER
Albrecht, G
Hamy, F
Citation: T. Klimkait et al., Rational optimization of a HIV-1 Tat inhibitor: Rapid progress on combinatorial lead structures, BIOTECH BIO, 61(3), 1998, pp. 155-168
Risultati:
1-11
|